Literature DB >> 15569357

Mitochondrial hTERT exacerbates free-radical-mediated mtDNA damage.

Janine Hertzog Santos1, Joel N Meyer, Milan Skorvaga, Lois A Annab, Bennett Van Houten.   

Abstract

Telomerase is often re-activated in human cancers and is widely used to immortalize cells in culture. In addition to the maintenance of telomeres, telomerase has been implicated in cell proliferation, genomic instability and apoptosis. Here we show that human telomerase reverse transcriptase (hTERT) is targeted to the mitochondria by an N-terminal leader sequence, and that mitochondrial extracts contain telomerase activity. In seven different human cell lines, mitochondrial telomerase increases hydrogen-peroxide-mediated mitochondrial DNA damage. hTERT expression did not alter the rate of hydrogen peroxide breakdown or endogenous cellular levels. Because the damaging effects of hydrogen peroxide are mediated by divalent metal ions (Fenton chemistry), we examined the levels of bioavailable metals. In all cases, higher levels of chelatable metals were found in hTERT-expressing cells. These results suggest that mitochondrial telomerase sensitizes cells to oxidative stress, which can lead to apoptotic cell death, and imply a novel function of telomerase in mitochondrial DNA transactions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15569357     DOI: 10.1111/j.1474-9728.2004.00124.x

Source DB:  PubMed          Journal:  Aging Cell        ISSN: 1474-9718            Impact factor:   9.304


  86 in total

1.  Separation of telomerase functions by reverse genetics.

Authors:  Shibani Mukherjee; Eduardo J Firpo; Yang Wang; James M Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

Review 2.  Biologic function and clinical potential of telomerase and associated proteins in cardiovascular tissue repair and regeneration.

Authors:  Rosalinda Madonna; Raffaele De Caterina; James T Willerson; Yong-Jian Geng
Journal:  Eur Heart J       Date:  2010-12-10       Impact factor: 29.983

Review 3.  The role of telomeres and telomerase reverse transcriptase isoforms in pluripotency induction and maintenance.

Authors:  Jonathan H Teichroeb; Joohwan Kim; Dean H Betts
Journal:  RNA Biol       Date:  2016-01-19       Impact factor: 4.652

Review 4.  Molecular mechanisms involved in endothelial cell aging: role of telomerase reverse transcriptase.

Authors:  S Jakob; J Haendeler
Journal:  Z Gerontol Geriatr       Date:  2007-10       Impact factor: 1.281

Review 5.  Mitochondrial energetics and therapeutics.

Authors:  Douglas C Wallace; Weiwei Fan; Vincent Procaccio
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

Review 6.  Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins.

Authors:  Paula Martínez; María A Blasco
Journal:  Nat Rev Cancer       Date:  2011-03       Impact factor: 60.716

Review 7.  Genetic and epigenetic trends in telomere research: a novel way in immunoepigenetics.

Authors:  Dora Melicher; Edit I Buzas; Andras Falus
Journal:  Cell Mol Life Sci       Date:  2015-07-20       Impact factor: 9.261

8.  The major reverse transcriptase-incompetent splice variant of the human telomerase protein inhibits telomerase activity but protects from apoptosis.

Authors:  Imke Listerman; Jie Sun; Francesca S Gazzaniga; Jason L Lukas; Elizabeth H Blackburn
Journal:  Cancer Res       Date:  2013-04-22       Impact factor: 12.701

9.  Nuclear protein tyrosine phosphatase Shp-2 is one important negative regulator of nuclear export of telomerase reverse transcriptase.

Authors:  Sascha Jakob; Peter Schroeder; Margarete Lukosz; Nicole Büchner; Ioakim Spyridopoulos; Joachim Altschmied; Judith Haendeler
Journal:  J Biol Chem       Date:  2008-10-01       Impact factor: 5.157

10.  Expression of (NES-)hTERT in cancer cells delays cell cycle progression and increases sensitivity to genotoxic stress.

Authors:  Olga A Kovalenko; Jessica Kaplunov; Utz Herbig; Sonia Detoledo; Edouard I Azzam; Janine H Santos
Journal:  PLoS One       Date:  2010-05-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.